Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 10 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; pyridoxine hydrochloride, quantity: 5 mg/ml; dexpanthenol, quantity: 2.5 mg/ml; nicotinamide, quantity: 25 mg/ml; cyanocobalamin, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. commonly, several b vitamin deficiencies may occur similtaneously. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7.

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - zinc sulfate - oral capsule - 220mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

colorama pharmaceuticals ltd - zinc sulfate - oral capsule - 220mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

cubic pharmaceuticals ltd - zinc sulfate - oral capsule - 220mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

cst pharma ltd - zinc sulfate - oral capsule - 220mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - zinc sulfate - oral capsule - 220mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

icarus pharmaceuticals ltd - zinc sulfate - oral capsule - 220mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

niche pharma ltd - zinc sulfate - oral capsule - 220mg

Estats Units - anglès - NLM (National Library of Medicine)

stratus pharmaceuticals inc - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin 500 [usp'u] in 1 g - first aid to help prevent infection in - minor cuts - scrapes - burns

Estats Units - anglès - NLM (National Library of Medicine)

ohio lab pharma - bacitracin zinc 400 units neomycin 3.5 mg polymyxin b sulfate 5,000 units, pramoxine hydrochloride 10 mg - first aid to help prevent infection in minor • cuts • scrapes • burns - first aid antibiotic - external analgesic do not use • if you are allergic to any of the ingredients • in the eyes • over large areas of the body • longer than 1 week unless directed by a doctor stop use and ask a doctor if • the condition persists or gets worse • a rash or other allergic reaction develops